Nilmadhab Roy

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Helicobacter Pylori Infection

Breast Cancer Cells

Top Venues

Dalton transactions (Cambridge, England : 2003)

This page only lists publications with an associated author ORCID identifier.

Publications

Anuja P K, Binoy Kar, Nilmadhab Roy, Priyankar Paira
Ru(ii)arene(N^N bpy/phen)-based RAPTA complexes for in vitro anti-tumour activity in human glioblastoma cancer cell lines and in vivo toxicity studies in a zebrafish model. RSC advances 12 (29) (2022)
Ashaparna Mondal, Shanooja Shanavas, Utsav Sen, Utpal Das, Nilmadhab Roy, Bipasha Bose, Priyankar Paira
Mitochondria-targeted half-sandwich iridium(iii)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468. RSC advances 12 (19) (2022)
Binoy Kar, Shanooja Shanavas, Apoorva H Nagendra, Utpal Das, Nilmadhab Roy, Sudhindra Pete, Ajay Sharma S, Sourav De, S K Ashok Kumar, Pothabathula Seshu Vardhan, Suban Kumar Sahoo, Debashis Panda, Sudheer Shenoy, Bipasha Bose, Priyankar Paira
Iridium(III)-Cp*-(imidazo[4,5- f ][1,10]phenanthrolin-2-yl)phenol analogues as hypoxia active, GSH-resistant cancer cytoselective and mitochondria-targeting cancer stem cell therapeutic agents. Dalton transactions (Cambridge, England : 2003) 51 (14) (2022)
Bidisha Sarkar, Ashaparna Mondal, Yukti Madaan, Nilmadhab Roy, Anbalagan Moorthy, Yung-Chih Kuo, Priyankar Paira
Luminescent anticancer ruthenium(ii)-p-cymene complexes of extended imidazophenanthroline ligands: synthesis, structure, reactivity, biomolecular interactions and live cell imaging. Dalton transactions (Cambridge, England : 2003) 48 (32) (2019)